Canaccord Genuity predicts 26% revenue increase for US cannabis market in 2022, says revenue likely to cross $30BProactive Investors • 10/27/21
Insider Cannabis: Time to buy US cannabis stocks - New York's legal gray area - Deals, deals, dealsBusiness Insider • 10/22/21
Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG GummyGlobeNewsWire • 10/20/21
Cannabis Jobs On The Rise: Here's What's Prompting A Surge In Marijuana EmploymentBenzinga • 10/19/21
Which Canadian Cannabis Company Is In the Best Position to Enter the U.S. Market?The Motley Fool • 09/08/21
Best Cannabis Stocks To Invest In Right Now? 2 For Your List For September 2021MarijuanaStocks • 08/27/21
Bullish Tuesday For Marijuana Stocks - Sundial, Aurora, Tilray & Cronos Among Top GainersBenzinga • 08/24/21
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured CannabinoidsGlobeNewsWire • 08/23/21